Atlas Trials

Experimental Vaccine for Prevention of Ebola Virus Infection

Clinical trial NCT00374309 · COMPLETED

Trial details

NCT number
NCT00374309
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Ebola Hemorrhagic FeverEbola Virus DiseaseEbola Virus VaccinesEnvelope Glycoprotein, Ebola VirusFilovirus
Start date
2006-09-05
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.